1. Fox CS et al.JAMA. 2004; 291:2851 2. Frost L et al. Arch Intern Med. 2004; 164:1675-1678 3. Studio AFFIRM. N Engl J Med 2002; 347:1825 4. Studio RACE. N Engl J Med 2002; 347:1834 5. Studio AIRCRAFT. J Am Coll Cardiol 2003; 41:1697 6. Studio STAF. J Am Coll Cardiol 2003; 41: 1690 7. Rodney H. N Engl J Med 2001; 344:1067 8. Harg RG et al.Ann Intern Med 1999; 131:492 9. Snow V et al. Ann Intern Med 2003; 139:1009 10.South Med J. 2003;96:1128-1132 11.Lars Frost et al. Arch Intern Med. 2004;164:1993-1998 12.Wang TJ et al. JAMA. 2004; 292:2471-2477. 13.Alboni P et al.N Engl J Med 2004; 351:2384-2391 14.Li-Fern Hsu et al. N Engl J Med 2004; 351:2373-2383 15.de Denus S et al. Arch Intern Med. 2005 Feb 14;165:258-262. 16.Wazni OM et al. Radiofrequency Ablation vs Antiarrhythmic Drugs as First-line Treatment of Symptomatic Atrial Fibrillation. A Randomized Trial. JAMA. 2005 Jun 1; 293:2634-2640. 17. Oral H et al. Circumferential Pulmonary-Vein Ablation for Chronic Atrial Fibrillation. N Engl J Med 2006 Mar 2; 354:934-941 18. Madrid A H et al. The role of angiotensin receptor blockers and/or angiotensin converting enzyme inhibitors in the prevention of atrial fibrillation in patients with cardiovascular diseases: meta-analysis of randomized controlled clinical trials. Pacing and Clinical Electrophysiology, 2004;27(10):1405-1410 19. Lafuente-Lafuente C et al. Antiarrhythmic Drugs for Maintaining Sinus Rhythm After Cardioversion of Atrial Fibrillation . A Systematic Review of Randomized Controlled Trials. Arch Intern Med. 2006 Apr 10;166:719-728. 20. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation. JACC 2006 Aug 15; 48:e149-246 21. Hart RG et al. Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation. Ann Intern Med 2007 Jun 19; 146.857-867 22. Aguilar M et al. Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks. Cochrane Database Syst Rev. 2007 Jul 18;3:CD006186. 23. Mant J et al. on the behalf pf the BAFYA investigators Midland Research Practices Network (MidReC). Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 2007 Aug 11; 370:493-503 24. Noheria A et al. Catheter ablation vs antiarrhythmic drug therapy for atrial fibrillation: a systematic review. Archives of Internal Medicine 2008; 168: 581-586
|
|
